Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Cancers|May 14, 2022
Cytokines: Can Cancer Get the Message?Rachel M Morris, Toni O Mortimer, Kim L O'NeillPlos One|March 3, 2022
Selection of human single domain antibodies (sdAb) against thymidine kinase 1 and their incorporation into sdAb-Fc antibody constructs for potential use in cancer therapyEdwin J Velazquez, Jordan D Cress, Tyler B Humpherys, et al.Plos One|November 30, 2023
TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cellsEliza E Bitter, Jonathan Skidmore, Carolyn I Allen, et al.Journal of Oncology|July 11, 2012
Thymidine kinase 1 upregulation is an early event in breast tumor formationMelissa M Alegre, Richard A Robison, Kim L O'NeillMedical Oncology (Northwood, London, England)|May 7, 2018
A review of HPRT and its emerging role in cancerMichelle H Townsend, Richard A Robison, Kim L O'NeillTechnology in Cancer Research & Treatment|November 19, 2005
The comet assay to determine the mode of cell death for the ultrasonic delivery of doxorubicin to human leukemia (HL-60 Cells) from Pluronic P105 micellesGhaleb A Husseini, Kim L O'Neill, William G PittPhytotherapy Research : PTR|October 24, 2014
The immunostimulating role of lichen polysaccharides: a reviewGajendra Shrestha, Larry L St Clair, Kim L O'NeillInternational Journal of Molecular Sciences|April 13, 2023
Characterizing the Interplay of Lymphocytes in Graves' DiseaseMackenzie Hansen, Abigail Cheever, K Scott Weber, et al.Immunologic Research|February 26, 2020
Paving the way towards universal treatment with allogenic T cellsMichelle H Townsend, Kelsey Bennion, Richard A Robison, et al.Journal of Experimental & Clinical Cancer Research : CR|July 23, 2018
The expansion of targetable biomarkers for CAR T cell therapyMichelle H Townsend, Gajendra Shrestha, Richard A Robison, et al.Pageof 5